Form 8-K - Current report:
SEC Accession No. 0001193125-24-219617
Filing Date
2024-09-16
Accepted
2024-09-16 16:18:27
Documents
3
Period of Report
2024-09-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d844648d8k.htm 8-K 19092
2 EX-3.1 d844648dex31.htm EX-3.1 29899
3 EX-3.2 d844648dex32.htm EX-3.2 122800
  Complete submission text file 0001193125-24-219617.txt   172951
Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 617-785-8308
Bicara Therapeutics Inc. (Filer) CIK: 0002023658 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42271 | Film No.: 241301260
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)